Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peng-Sheng Yi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular and Clinical Oncology|May 8, 2018
High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinomaPeng Sheng Yi, Jian Shui Li
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|July 31, 2015
Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysisPeng-Sheng Yi, Ming Zhang, Ming-Qing Xu
World Journal of Gastrointestinal Surgery|March 29, 2020
Evolution and current status of the subclassification of intermediate hepatocellular carcinomaPeng-Sheng Yi, Hong Wang, Jian-Shui Li
Hepatobiliary & Pancreatic Diseases International : HBPD INT|March 30, 2016
Role of microRNA in liver regenerationPeng-Sheng Yi, Ming Zhang, Ming-Qing Xu
World Journal of Hepatology|May 19, 2016
Liver resection for intermediate hepatocellular carcinomaPeng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, et al.
The American Surgeon|March 28, 2018
Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy <i>versus</i> Surgical Resection for Early Hepatocellular CarcinomaPeng-Sheng Yi, Min Huang, Ming Zhang, et al.
BMC Surgery|December 1, 2023
Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysisShan Huang, Jiu-Lin Song, Bo Li, et al.
Frontiers in Surgery|November 28, 2022
The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experiencePeng-Sheng Yi, Jun-Ning Liu, Yong Li, et al.
Frontiers in Oncology|March 13, 2023
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysisJun-Ning Liu, Ji-Jiang Li, Shu Yan, et al.
Scandinavian Journal of Gastroenterology|March 19, 2019
Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinomaPeng Sheng Yi, Yong Li, Shu Yan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular and Clinical Oncology|May 8, 2018
High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinomaPeng Sheng Yi, Jian Shui Li
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|July 31, 2015
Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysisPeng-Sheng Yi, Ming Zhang, Ming-Qing Xu
World Journal of Gastrointestinal Surgery|March 29, 2020
Evolution and current status of the subclassification of intermediate hepatocellular carcinomaPeng-Sheng Yi, Hong Wang, Jian-Shui Li
Hepatobiliary & Pancreatic Diseases International : HBPD INT|March 30, 2016
Role of microRNA in liver regenerationPeng-Sheng Yi, Ming Zhang, Ming-Qing Xu
World Journal of Hepatology|May 19, 2016
Liver resection for intermediate hepatocellular carcinomaPeng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, et al.
The American Surgeon|March 28, 2018
Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy <i>versus</i> Surgical Resection for Early Hepatocellular CarcinomaPeng-Sheng Yi, Min Huang, Ming Zhang, et al.
BMC Surgery|December 1, 2023
Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysisShan Huang, Jiu-Lin Song, Bo Li, et al.
Frontiers in Surgery|November 28, 2022
The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experiencePeng-Sheng Yi, Jun-Ning Liu, Yong Li, et al.
Frontiers in Oncology|March 13, 2023
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysisJun-Ning Liu, Ji-Jiang Li, Shu Yan, et al.
Scandinavian Journal of Gastroenterology|March 19, 2019
Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinomaPeng Sheng Yi, Yong Li, Shu Yan, et al.
Pageof 2